Health Canada, May 3, 2006
2006-25
May 3, 2006
Warning
For immediate release
Health Canada warns consumers not to use Nasutra due to potential health risks
OTTAWA - Health Canada is warning consumers not
to use the product Nasutra because it has been found to contain the
undeclared ingredient sildenafil (chemical name for ViagraTM) that
could lead to serious health risks, especially for patients with
existing medical conditions such as heart problems, those who may be
taking heart medications, or those who may be at risk for
strokes.
Nasutra is advertised as an all-natural traditional Chinese
medicine for sexual enhancement, but it was found to contain
sildenafil, which should only be used under medical supervision.
Sildenafil has also been associated with serious side-effects
including sudden vision loss, penile tissue damage and urinary tract
infection.
This product is not authorized for sale in Canada, but it may be
available to Canadian consumers through the Internet, personal
importation, or other venues. Canadians who may have purchased
Nasutra over the Internet or while travelling abroad are warned not
to use it, and to consult with a health care professional if they
have concerns about their health due to this product.
Nasutra has been found for sale in New Zealand. As a result, the
New Zealand Medicines and Medical Devices Safety Authority tested
the product and issued a warning advising the public not to purchase
or consume the product Nasutra.
The text in this article was prepared by Health Canada.